Moria's new microkeratome, One Use-Plus SBK, outperforms Femto-LASIK, it was announced at this year's meeting of the American Society of Cataract and Refractive Surgery (ASCRS).
Moria's new microkeratome, One Use-Plus SBK, outperforms Femto-LASIK, it was announced at this year's meeting of the American Society of Cataract and Refractive Surgery (ASCRS).
Richard J. Duffey, MD of Premier Medical Eye Group, Alabama, US compared flap thickness predictability, speed of visual recovery, higher order aberrations, smoothness of stromal bed and patient comfort between the two techniques. Dr Duffey has no financial interest in Moria or the One Use-Plus SBK.
For every variable, the One Use-Plus compared equally or favourably with Femto-LASIK, with none of the associated complications of the latter device. Postoperative pain in the first one to five hours was lower in both frequency and intensity when using the One Use-Plus than with Femto-LASIK.
Dr Duffey concluded that the One Use-Plus was a better option for both patients and surgeons than Femto-LASIK.
AAO 2024: Transient vision loss with Alexander Fein, MD
October 21st 2024Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.
AAO 2024: Optimal pupil size reduction percentage for near vision improvement in presbyopia
October 21st 2024Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.